- Home
- ELME vs ATAI Comparison
ELME vs ATAI Comparison
Compare ELME & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELME | ATAI |
|---|---|---|
| Founded | 1960 | 2018 |
| Country | United States | Netherlands |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.4B |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | ELME | ATAI |
|---|---|---|
| Price | $17.37 | $4.32 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $15.00 | $14.00 |
| AVG Volume (30 Days) | 1.7M | ★ 3.6M |
| Earning Date | 10-23-2025 | 11-12-2025 |
| Dividend Yield | ★ 4.14% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $246,959,000.00 | $3,018,000.00 |
| Revenue This Year | N/A | $943.83 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 3.10 | ★ 811.78 |
| 52 Week Low | $13.95 | $1.15 |
| 52 Week High | $18.08 | $6.75 |
Technical Indicators
Market Signals| Indicator | ELME | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 64.36 | 49.78 |
| Support Level | $16.38 | $4.25 |
| Resistance Level | $17.34 | $4.54 |
| Average True Range (ATR) | 0.12 | 0.22 |
| MACD | 0.01 | 0.10 |
| Stochastic Oscillator | 80.56 | 71.36 |
Price Performance
Historical ComparisonAbout ELME Elme Communities
Elme Communities is a real estate investment trust engaged in owning and operating properties in the greater Washington DC metropolitan area. The company's real estate portfolio is comprised of office, retail, and multifamily properties located near transportation nodes. Washington REIT derives nearly all of its income in the form of rental revenue from tenants organized into long-term leases. The company's office assets contribute the majority of this income, while the rest is split fairly evenly between its retail and multifamily locations. Washington REIT's tenants are banking, consulting, law, and financial services firms.
About ATAI ATAI Life Sciences N.V.
Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.